Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells

Harry Lee(North Carolina Central University), Xiaohe Yang(North Carolina Central University)
Scientific Reports
April 25, 2018
Cited by 24


Related Papers